:: Volume 21, Issue 1 (1-2023) ::
Int J Radiat Res 2023, 21(1): 173-176 Back to browse issues page
Osteomalacia mimicking skeletal metastasis induced by antacid and sucralfate: An interesting image on bone scintigraphy
Y-W Chuang , H-P Chan , C-Y Lin , Y-F Huang , C-C Hsu , C-C Chang , D. H-Y Shen , K-P Chuang , M-H Yang , Y-C Tyan
Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan , mhyang@vghks.gov.tw
Abstract:   (547 Views)
Phosphate absorption can be blocked by over-the-counter antacids, such as calcium- magnesium-, and aluminum-containing products. Although it is rare to see hypophosphatemia induced by aluminum-containing antacids, the combination treatment using two kinds of aluminum-containing agents may significantly increase the risk of hypophosphatemia in clinical settings. We present a case of hepatocellular carcinoma, showing multiple hot spots while being investigated for metastatic cancer in a routine bone scan. Initial laboratory studies showed hypophosphatemia. Long-term treatment for upper gastrointestinal bleeding with antacids and sucralfate was remarkable in the patient’s past history. Compared with corresponding radiographic findings, multiple areas of increased uptake on the bone scan are consistent with osteomalacia and microfractures. This case demonstrates that antacid and sucralfate-induced osteomalacia can mimic bony metastasis in a hepatocellular carcinoma patient on bone scintigraphy. Additional imaging modality, laboratory surveillance or follow-up bone scintigraphy may be recommended for accurate diagnosis or an appropriate treatment plan for the patient.
Keywords: Bone scan, antacid, sucralfate, hypophosphatemic osteomalacia.
Full-Text [PDF 969 kb]   (480 Downloads)    
Type of Study: Case Report | Subject: Radiation Biology
1. Liamis G, Milionis HJ, Elisaf M (2010) Medication-induced hypophosphatemia: a review. QJM, 103(7): 449-459. [DOI:10.1093/qjmed/hcq039] [PMID]
2. Herzog P and Holterm├╝ller KH (1982) Antacid therapy--changes in mineral metabolism. Scand J Gastroenterol Suppl, 75: 56-62.
3. Megapanou E, Florentin M, Milionis H, Elisaf M, Liamis G (2020) Drug-Induced Hypophosphatemia: Current Insights. Drug Saf, 43(3): 197-210. [DOI:10.1007/s40264-019-00888-1] [PMID]
4. Serna J and Bergwitz C (2020) Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. Nutrients, 12(10): 3001. [DOI:10.3390/nu12103001] [PMID] []
5. Cooke N, Teitelbaum S, Avioli LV (1978) Antacid-induced osteomalacia and nephrolithiasis. Arch Intern Med, 138(6): 1007-1009. [DOI:10.1001/archinte.1978.03630310083028]
6. Boutsen Y, Devogelaer JP, Malghem J, Noel H, Nagant de Deuxchaisnes C (1996) Antacid-induced osteomalacia. Clin Rheumatol, 15(1): 75-80. [DOI:10.1007/BF02231691] [PMID]
7. Chines A and Pacifici R (1990) Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int, 47(5): 291-295. [DOI:10.1007/BF02555911] [PMID]
8. Kassem M, Eriksen EF, Melsen F, Mosekilde L (1991) Antacid-induced osteomalacia: a case report with a histomorphometric analysis. J Intern Med, 229(3): 275-279. [DOI:10.1111/j.1365-2796.1991.tb00344.x] [PMID]
9. Woodson GC (1998) An interesting case of osteomalacia due to antacid use associated with stainable bone aluminum in a patient with normal renal function. Bone, 22(6): 695-698. [DOI:10.1016/S8756-3282(98)00060-X]
10. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers, 3: 17044. [DOI:10.1038/nrdp.2017.44] [PMID]
11. Aligail K, Dave JA, Ross IL (2022) Tumor-induced osteomalacia: a case report. J Med Case Rep, 16(1): 22. [DOI:10.1186/s13256-021-03220-7] [PMID] []
12. Yin Z, Du J, Yu F, Xia W (2018) Tumor-induced osteomalacia. Osteoporos Sarcopenia, 4(4): 119-127. [DOI:10.1016/j.afos.2018.12.001] [PMID] []
13. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers, 3: 17044. [DOI:10.1038/nrdp.2017.44] [PMID]
14. Velazquez-Navarro JA, Loya-Teruel E, Rios-Gomez M, Montes-Ramirez JE (2022) Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria. Cureus, 14(1): e20893. [DOI:10.7759/cureus.20893] [PMID] []
15. Beil FT, St├╝rznickel J, Rolvien T, Amling M, Oheim R (2022) Tumor localization and treatment of tumor-induced osteomalacia. Z Rheumatol, 81(3): 182-188. [DOI:10.1007/s00393-022-01160-1] [PMID]
16. Ukinc K (2009) Severe osteomalacia presenting with multiple vertebral fractures: a case report and review of the literature. Endocrine, 36(1): 30-36. [DOI:10.1007/s12020-009-9209-8] [PMID]
17. Kim SH, Won KS, Song BI, Jo I, Zeon SK (2013) Low-dose adefovir-induced hypophosphatemic osteomalacia on whole-body bone scintigraphy. Nucl Med Mol Imaging, 47(4): 294-296. [DOI:10.1007/s13139-013-0223-7] [PMID] []
18. Tanaka M, Setoguchi T, Ishidou Y, Arishima Y, Hirotsu M, Saitoh Y, et al. (2012) Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol, 7: 108. [DOI:10.1186/1746-1596-7-108] [PMID] []
19. Sood A, Agarwal K, Shukla J, Goel R, Dhir V, Bhattacharya A, Rai Mittal B (2013) Bone scintigraphic patterns in patients of tumor induced osteomalacia. Indian J Nucl Med, 28(3): 173-5. [DOI:10.4103/0972-3919.119541] [PMID] []
20. Sadineni RT, Pasumarthy A, Bellapa NC, Velicheti S (2015) Imaging Patterns in MRI in Recent Bone Injuries Following Negative or Inconclusive Plain Radiographs. J Clin Diagn Res, 9(10): TC10-TC13. [DOI:10.7860/JCDR/2015/15451.6685] [PMID] []

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 1 (1-2023) Back to browse issues page